CSTL1
gene geneOn this page
Also known as dJ322G13.4CTES1
Summary
CSTL1 (cystatin like 1, HGNC:15958) is a protein-coding gene on chromosome 20p11.21, encoding Cystatin-like 1 (Q9H114).
The cystatin superfamily encompasses proteins that contain multiple cystatin-like sequences. Some of the members are active cysteine protease inhibitors, while others have lost or perhaps never acquired this inhibitory activity. There are three inhibitory families in the superfamily, including the type 1 cystatins (stefins), type 2 cystatins and the kininogens. The type 2 cystatin proteins are a class of cysteine proteinase inhibitors found in a variety of human fluids and secretions. The cystatin locus on chromosome 20 contains the majority of the type 2 cystatin genes and pseudogenes. This gene is located at the telomeric end of the cystatin locus and encodes a type 2 cystatin-like protein. The specific function of this protein has not been determined.
Source: NCBI Gene 128817 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 32 total — 1 pathogenic
- MANE Select transcript:
NM_138283
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15958 |
| Approved symbol | CSTL1 |
| Name | cystatin like 1 |
| Location | 20p11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | dJ322G13.4, CTES1 |
| Ensembl gene | ENSG00000125823 |
| Ensembl biotype | protein_coding |
| Entrez | 128817 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 2 protein_coding, 2 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000246020, ENST00000347397, ENST00000472140, ENST00000485969, ENST00000619238
RefSeq mRNA: 1 — MANE Select: NM_138283
NM_138283
CCDS: CCDS13153
Canonical transcript exons
ENST00000347397 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001129203 | 23439685 | 23439806 |
| ENSE00001131433 | 23444771 | 23444930 |
| ENSE00001376763 | 23443934 | 23444044 |
| ENSE00003523083 | 23440144 | 23440486 |
Expression profiles
Bgee: expression breadth broad, 64 present calls, max score 85.68.
Top tissues by expression
201 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.68 | gold quality |
| right testis | UBERON:0004534 | 75.24 | gold quality |
| left testis | UBERON:0004533 | 74.83 | gold quality |
| testis | UBERON:0000473 | 72.52 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 61.59 | gold quality |
| sperm | CL:0000019 | 57.18 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 49.56 | gold quality |
| buccal mucosa cell | CL:0002336 | 49.24 | gold quality |
| esophagus mucosa | UBERON:0002469 | 47.74 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| lower lobe of lung | UBERON:0008949 | 42.35 | silver quality |
| granulocyte | CL:0000094 | 41.92 | silver quality |
| right lobe of liver | UBERON:0001114 | 41.62 | silver quality |
| vastus lateralis | UBERON:0001379 | 41.41 | gold quality |
| quadriceps femoris | UBERON:0001377 | 41.37 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| oviduct epithelium | UBERON:0004804 | 41.17 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 41.10 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| skin of leg | UBERON:0001511 | 40.82 | gold quality |
| amniotic fluid | UBERON:0000173 | 40.69 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
| biceps brachii | UBERON:0001507 | 40.57 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 40.45 | gold quality |
| myocardium | UBERON:0002349 | 40.45 | gold quality |
| gingival epithelium | UBERON:0001949 | 40.43 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 40.33 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 40.29 | gold quality |
| zone of skin | UBERON:0000014 | 40.28 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.61 |
Regulation
Is transcription factor: no
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:busm1-57f23.1 | ENSDARG00000074425 |
| mus_musculus | Cstl1 | ENSMUSG00000055177 |
| rattus_norvegicus | Cstl1 | ENSRNOG00000004779 |
| caenorhabditis_elegans | WBGENE00000534 | |
| caenorhabditis_elegans | WBGENE00000535 | |
| caenorhabditis_elegans | WBGENE00023486 |
Paralogs (11): CST7 (ENSG00000077984), CST9L (ENSG00000101435), CST3 (ENSG00000101439), CST4 (ENSG00000101441), CST8 (ENSG00000125815), CST11 (ENSG00000125831), CST5 (ENSG00000170367), CST2 (ENSG00000170369), CST1 (ENSG00000170373), CST9 (ENSG00000173335), CST6 (ENSG00000175315)
Protein
Protein identifiers
Cystatin-like 1 — Q9H114 (reviewed: Q9H114)
Alternative names: RCET11
All UniProt accessions (1): Q9H114
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
Similarity. Belongs to the cystatin family.
RefSeq proteins (1): NP_612140* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000010 | Cystatin_dom | Domain |
| IPR042921 | CSTL1 | Family |
| IPR046350 | Cystatin_sf | Homologous_superfamily |
Pfam: PF00031
UniProt features (11 total): sequence variant 5, disulfide bond 2, signal peptide 1, chain 1, domain 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H114-F1 | 85.45 | 0.61 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (2): 91–101, 114–134
Glycosylation sites (1): 42
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 32 (showing top):
GOBP_PROTEIN_MATURATION, GOMF_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY, GOBP_PROTEOLYSIS, GOMF_PEPTIDASE_REGULATOR_ACTIVITY, GOMF_PEPTIDASE_ACTIVITY, chr20p11, GOMF_ENZYME_INHIBITOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN, GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY, GOBP_PROTEIN_PROCESSING, GOMF_ENDOPEPTIDASE_REGULATOR_ACTIVITY, GOBP_SIGNALING_RECEPTOR_LIGAND_PRECURSOR_PROCESSING, NABA_ECM_REGULATORS, GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_DN
GO Biological Process (3): transmission of nerve impulse (GO:0019226), G protein-coupled opioid receptor signaling pathway (GO:0038003), signaling receptor ligand precursor processing (GO:0140448)
GO Molecular Function (3): cysteine-type endopeptidase inhibitor activity (GO:0004869), cysteine-type peptidase activity (GO:0008234), peptidase inhibitor activity (GO:0030414)
GO Cellular Component (1): extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| peptidase activity | 2 |
| action potential | 1 |
| cell communication | 1 |
| chemical synaptic transmission | 1 |
| nervous system process | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| protein processing | 1 |
| cysteine-type endopeptidase activity | 1 |
| endopeptidase inhibitor activity | 1 |
| enzyme inhibitor activity | 1 |
| peptidase regulator activity | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
318 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CSTL1 | CST9 | Q5W186 | 582 |
| CSTL1 | GZF1 | Q9H116 | 512 |
| CSTL1 | IQCF6 | A8MYZ5 | 471 |
| CSTL1 | NXT1 | Q9UKK6 | 451 |
| CSTL1 | CTSB | P07858 | 428 |
| CSTL1 | CST3 | P01034 | 421 |
| CSTL1 | ACSS1 | Q9NUB1 | 404 |
| CSTL1 | OR1F1 | O43749 | 400 |
| CSTL1 | PATE3 | B3GLJ2 | 399 |
| CSTL1 | KRTAP5-7 | Q6L8G8 | 397 |
| CSTL1 | OR2AE1 | Q8NHA4 | 394 |
| CSTL1 | RNF32 | Q9H0A6 | 373 |
| CSTL1 | TPM3 | P06753 | 368 |
| CSTL1 | NPIPB13 | A6NJU9 | 359 |
| CSTL1 | L3HYPDH | Q96EM0 | 348 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CSTL1 | DENND11 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (56): HBA2 (Affinity Capture-MS), GOLIM4 (Affinity Capture-MS), MZT2B (Affinity Capture-MS), RCCD1 (Affinity Capture-MS), FN1 (Affinity Capture-MS), FBXO2 (Affinity Capture-MS), SUSD5 (Affinity Capture-MS), KDM8 (Affinity Capture-MS), TMEM131 (Affinity Capture-MS), DHFRL1 (Affinity Capture-MS), PTPRK (Affinity Capture-MS), LOXL2 (Affinity Capture-MS), PPTC7 (Affinity Capture-MS), UBE2Q1 (Affinity Capture-MS), GPR98 (Affinity Capture-MS)
ESM2 similar proteins: A0A0K0IP23, A0A1S3PBB7, B2Z450, E3P6N3, E3P6N4, E3P6N5, E3P6N6, E3P6N7, E3P6N8, E3P6N9, E3P6P0, E3P6P1, E3P6P2, E3P6P3, E3P6P4, J3RYX9, J3SE80, O60676, O88969, O97862, P01036, P01037, P01038, P01048, P08932, P08935, P09228, P19313, P28325, P32766, P33046, P35481, P49928, P49929, P49930, P54229, P54230, P81714, Q15828, Q2XXN5
Diamond homologs: B2Z450, E3P6N3, E3P6N7, E3P6N8, E3P6N9, E3P6P0, E3P6P3, J3RYX9, J3SE80, O19092, O19093, O89098, O97862, P01034, P01035, P01038, P08935, P14841, P19313, P21460, P35481, P81061, Q15828, Q2XXN5, Q6T6T4, Q80ZN5, Q91195, Q98967, Q9H114, B1P1J3, E3P6N4, E3P6N5, E3P6N6, E3P6P1, E3P6P2, E3P6P4, O60676, O76096, O88969, P01036
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
32 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 24 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 3024619 | GRCh37/hg19 20p13-11.21(chr20:68351-23860313)x3 | Pathogenic |
SpliceAI
504 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:23443932:A:AG | acceptor_gain | 0.9900 |
| 20:23443933:G:GG | acceptor_gain | 0.9900 |
| 20:23444769:A:AG | acceptor_gain | 0.9700 |
| 20:23444770:G:GG | acceptor_gain | 0.9700 |
| 20:23444770:GA:G | acceptor_gain | 0.9700 |
| 20:23439802:GGAAG:G | donor_gain | 0.9500 |
| 20:23439803:GAAGG:G | donor_gain | 0.9500 |
| 20:23443933:GCT:G | acceptor_gain | 0.9500 |
| 20:23439804:A:T | donor_gain | 0.9400 |
| 20:23439804:AAGGT:A | donor_loss | 0.9400 |
| 20:23439806:GGTAA:G | donor_loss | 0.9400 |
| 20:23439808:T:G | donor_loss | 0.9400 |
| 20:23443928:C:CA | acceptor_gain | 0.9400 |
| 20:23443680:G:GC | acceptor_gain | 0.9300 |
| 20:23443929:GGCA:G | acceptor_loss | 0.9300 |
| 20:23443930:GCA:G | acceptor_loss | 0.9300 |
| 20:23443931:CA:C | acceptor_loss | 0.9300 |
| 20:23443928:CGGCA:C | acceptor_loss | 0.9200 |
| 20:23440482:TGCAG:T | donor_loss | 0.9000 |
| 20:23440483:GCAGG:G | donor_loss | 0.9000 |
| 20:23440484:CAG:C | donor_loss | 0.9000 |
| 20:23440485:AG:A | donor_loss | 0.9000 |
| 20:23440486:GGTT:G | donor_loss | 0.9000 |
| 20:23440487:G:T | donor_loss | 0.9000 |
| 20:23440488:T:A | donor_loss | 0.9000 |
| 20:23443679:TG:T | acceptor_gain | 0.9000 |
| 20:23443929:G:A | acceptor_gain | 0.9000 |
| 20:23443933:GC:G | acceptor_gain | 0.9000 |
| 20:23444036:C:G | donor_gain | 0.9000 |
| 20:23440489:TTG:T | donor_loss | 0.8900 |
AlphaMissense
954 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:23440406:T:C | F47L | 0.898 |
| 20:23440408:C:A | F47L | 0.898 |
| 20:23440408:C:G | F47L | 0.898 |
| 20:23440358:T:C | F31L | 0.897 |
| 20:23440360:C:A | F31L | 0.897 |
| 20:23440360:C:G | F31L | 0.897 |
| 20:23444809:G:C | W123C | 0.847 |
| 20:23444809:G:T | W123C | 0.847 |
| 20:23444830:G:C | W130C | 0.811 |
| 20:23444830:G:T | W130C | 0.811 |
| 20:23444819:T:C | F127L | 0.791 |
| 20:23444821:C:A | F127L | 0.791 |
| 20:23444821:C:G | F127L | 0.791 |
| 20:23440359:T:G | F31C | 0.789 |
| 20:23440475:A:C | S70R | 0.774 |
| 20:23440477:T:A | S70R | 0.774 |
| 20:23440477:T:G | S70R | 0.774 |
| 20:23440418:T:C | S51P | 0.768 |
| 20:23443959:T:A | V82D | 0.768 |
| 20:23444786:T:C | S116P | 0.762 |
| 20:23444780:T:A | C114S | 0.758 |
| 20:23444781:G:C | C114S | 0.758 |
| 20:23443980:C:T | T89I | 0.753 |
| 20:23440426:C:A | N53K | 0.740 |
| 20:23440426:C:G | N53K | 0.740 |
| 20:23444793:T:A | I118K | 0.736 |
| 20:23440421:T:G | Y52D | 0.717 |
| 20:23440479:A:C | Q71P | 0.715 |
| 20:23440433:A:C | S56R | 0.713 |
| 20:23440435:C:A | S56R | 0.713 |
dbSNP variants (sampled 300 via entrez): RS1000081997 (20:23459473 T>C), RS1000253936 (20:23455664 G>A,C,T), RS1000283614 (20:23455991 A>T), RS1000436925 (20:23438481 C>T), RS1000512010 (20:23450768 G>A), RS1000549848 (20:23442286 C>T), RS1000648510 (20:23445060 C>A,T), RS1001038963 (20:23447907 T>C), RS1001116216 (20:23458501 T>G), RS1001125831 (20:23438901 C>A), RS1001286524 (20:23454639 G>A), RS1001410668 (20:23454050 AACAC>A,AAC), RS1001488160 (20:23446742 C>G), RS1001610805 (20:23443449 A>C), RS1001646257 (20:23460882 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| perfluorooctanoic acid | increases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Cadmium | decreases expression | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.